Skip to main content
. 2022 Jan 17;29(1):305–315. doi: 10.1080/10717544.2021.2023704

Figure 6.

Figure 6.

(A) Retention of nanoparticles in mucus. (B) Absorption of nanoparticles during the in vivo intestinal circulation. (C) Absorption of nanoparticles during the in vitro flip-flop intestinal circulation. Compared with the D-NPS group, **p < .01; ***p < .001.